Verrica Pharmaceuticals Inc (VRCA) — Cash Flow-to-Debt Ratio
Verrica Pharmaceuticals Inc (VRCA) has a Cash Flow-to-Debt Ratio of -0.40x as of March 2026, meaning its operating cash flow of $-9.16 Million could theoretically repay 0% of its total liabilities ($22.73 Million) in one year. Check Verrica Pharmaceuticals Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Verrica Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Verrica Pharmaceuticals Inc across 10 annual periods. Also explore Verrica Pharmaceuticals Inc total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Verrica Pharmaceuticals Inc (2016–2025)
Year-by-year debt coverage analysis for Verrica Pharmaceuticals Inc. For market capitalisation and broader financial context, see VRCA company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.79x | $-17.63 Million | $22.39 Million | ▲ +17.3% |
| 2024 | -0.95x | $-60.93 Million | $63.99 Million | ▼ -52.6% |
| 2023 | -0.62x | $-38.58 Million | $61.83 Million | ▲ +84.3% |
| 2022 | -3.98x | $-18.65 Million | $4.69 Million | ▼ -585.4% |
| 2021 | -0.58x | $-27.58 Million | $47.52 Million | ▲ +20.9% |
| 2020 | -0.73x | $-30.21 Million | $41.17 Million | ▲ +90.9% |
| 2019 | -8.04x | $-27.41 Million | $3.41 Million | ▼ -11.4% |
| 2018 | -7.22x | $-17.87 Million | $2.48 Million | ▼ -2438.7% |
| 2017 | -0.28x | $-4.58 Million | $16.12 Million | ▲ +43.4% |
| 2016 | -0.50x | $-1.61 Million | $3.21 Million | — |